Deanna Woodroffe
Women's Health · Lone Tree, CONPI 1770772451
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 48.3% of the total. Reporting peaked in 2022 at $246 and has fallen 75.3% since, to $61 in 2025.
Across 32 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$295
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$96
- Amneal Pharmaceuticals LLC$33
- Evofem Biosciences, Inc.$23
- Pfizer$20
- Exeltis, USA Inc.$18
- plus $125 from 8 others
What the payments were for
- Food & beverage$610100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $295 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $96 |
| Amneal Pharmaceuticals LLC | 2 | $33 |
| Evofem Biosciences, Inc. | 1 | $23 |
| Pfizer | 1 | $20 |
| Exeltis, USA Inc. | 1 | $18 |
| Bayer | 1 | $17 |
| Tempus AI, Inc | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Acerus Pharmaceuticals Corporation | 1 | $16 |
| Acella Pharmaceuticals, LLC | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Coopersurgical, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORIAHNN$117
How this compares
$610 in reported general payments places this provider in the 75th percentile of 165 women's health providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 198 | $8,616 |
| Estradiol (Twice Weekly)Estradiol | 45 | $5,074 |
| DottiEstradiol | 31 | $4,682 |
| Liothyronine Sodium | 66 | $4,141 |
| LyllanaEstradiol | 22 | $3,440 |
| Testosterone Cypionate | 28 | $1,746 |
| Levothyroxine Sodium | 132 | $1,397 |
| Estradiol | 57 | $1,338 |
| Np ThyroidThyroid,pork | 18 | $1,217 |
| SynthroidLevothyroxine Sodium | 13 | $850 |
| ThyroidThyroid,pork | 16 | $386 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $33 | $1,397132 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $16 | $1,21718 claims |
| AbbVieSynthroid | $295 | $85013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 165 women's health providers in Colorado.
Other women's health in Lone Tree
- Julie MarshallLone Tree$12K
- Rita WinnLone Tree$3K
- Amanda RoyLone Tree$1K
- Elizabeth NordquistLone Tree$1K
- Hannah KuklaLone Tree$824
- Elizabeth JanichLone Tree$715
- Anita WolfeLone Tree$656
- Jane Kass-WolffAurora$8K
- Hisae TsurumiAurora$6K
- Ladean MarshallDenver$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.